GeneDx Holdings
111 hedge funds and large institutions have $202M invested in GeneDx Holdings in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 50 increasing their positions, 17 reducing their positions, and 27 closing their positions.
4,463% more call options, than puts
Call options by funds: $1.09M | Put options by funds: $24K
194% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 17
11% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 27
3% more funds holding
Funds holding: 108 → 111 (+3)
0.08% less ownership
Funds ownership: 1.37% → 1.29% (-0.08%)
40% less capital invested
Capital invested by funds: $337M → $202M (-$135M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
+$23.5M |
| 2 |
CM
Corvex Management
New York
|
+$23.5M |
| 3 |
BlackRock
New York
|
+$21.1M |
| 4 |
DM
Deerfield Management
New York
|
+$10.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.55M |
| 2 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
-$2.63M |
| 3 |
IM
Islet Management
New York
|
-$2.61M |
| 4 |
Millennium Management
New York
|
-$2.06M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.97M |
WGS Hedge Fund Activity: Q2 2022 in Review
111 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in GeneDx Holdings (WGS) for Q2 2022, worth a combined $202M — down 40% from $337M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new WGS positions and 27 closed out — a net gain of 3 holders — while 50 added to existing stakes and 17 trimmed.
The largest buyer was Casdin Capital, adding an estimated $23.5M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $3.55M sold.
- 111 institutional investors held GeneDx Holdings (WGS) as of Q2 2022, up from 108 in Q1 2022.
- Funds reported $202M of GeneDx Holdings stock for Q2 2022, down 40% quarter-over-quarter.
- 30 funds opened new GeneDx Holdings positions in Q2 2022 and 27 closed out, a net change of +3 holders.
- The largest GeneDx Holdings buyer in Q2 2022 was Casdin Capital, an estimated $23.5M added.
- The largest GeneDx Holdings seller in Q2 2022 was Driehaus Capital Management, an estimated $3.55M sold.
Based on aggregated 13F filings for Q2 2022.